Treatment Options in Metastatic Castration-Sensitive Prostate Cancer

被引：0
|
作者：
Choudhury, Atish D. [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02215 USA
来源：
ONCOLOGY-NEW YORK | 2022年 / 36卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：184 / 185
页数：2
相关论文
共 50 条
  • [41] A cost-utility analysis of apalutamide for the treatment of patients with metastatic castration-sensitive prostate cancer (mCSPC).
    Parmar, Ambika
    Timilshina, Narhari
    Emmenegger, Urban
    Alibhai, Shabbir M. H.
    Smoragiewicz, Martin
    Sander, Beate
    Chan, Kelvin K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [42] Treatment Strategies for Metastatic Castration-Sensitive Prostate Cancer: From "All-Comers" to "Personalized" Approach
    Harada, Kenichi
    Shiota, Masaki
    Minato, Akinori
    Matsumoto, Masahiro
    Tomisaki, Ikko
    Fujisawa, Masato
    Fujimoto, Naohiro
    [J]. ONCOTARGETS AND THERAPY, 2021, 14 : 2967 - 2974
  • [43] First-line Systemic Treatment Options for Metastatic Castration-Sensitive Prostate Cancer A Living Systematic Review and Network Meta-analysis
    Riaz, Irbaz Bin
    Naqvi, Syed Arsalan Ahmed
    He, Huan
    Asghar, Noureen
    Siddiqi, Rabbia
    Liu, Hongfang
    Singh, Parminder
    Childs, Daniel S.
    Ravi, Praful
    Hussain, Syed A.
    Murad, Mohammad Hassan
    Boorjian, Stephen A.
    Sweeney, Christopher
    Van Allen, Eliezer M.
    Bryce, Alan H.
    [J]. JAMA ONCOLOGY, 2023, 9 (05) : 635 - 645
  • [44] Phenotypes of circulating tumour cells predict time to castration resistance in metastatic castration-sensitive prostate cancer
    Yang, Yun-Jie
    Kong, Yun-Yi
    Li, Gao-Xiang
    Wang, Yue
    Ye, Ding-Wei
    Dai, Bo
    [J]. BJU INTERNATIONAL, 2019, 124 (02) : 258 - 267
  • [45] Oncogenic Genomic Alterations, Clinical Phenotypes, and Outcomes in Metastatic Castration-Sensitive for Prostate Cancer
    Stopsack, Konrad H.
    Nandakumar, Subhiksha
    Wibmer, Andreas G.
    Haywood, Samuel
    Weg, Emily S.
    Barnett, Ethan S.
    Kim, Chloe J.
    Carbone, Emily A.
    Vasselman, Samantha E.
    Nguyen, Bastien
    Hullings, Melanie A.
    Scher, Howard I.
    Morris, Michael J.
    Solit, David B.
    Schultz, Nikolaus
    Kantoff, Philip W.
    Abida, Wassim
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (13) : 3230 - 3238
  • [46] Docetaxel or abiraterone in addition to androgen deprivation therapy in metastatic castration-sensitive prostate cancer
    Bilgin, Burak
    Sendur, Mehmet A. N.
    Hizal, Mutlu
    Akinci, Muhammed Bulent
    Dede, Didem Sener
    Yalcin, Bulent
    [J]. FUTURE ONCOLOGY, 2017, 13 (22) : 1911 - 1913
  • [47] Real-world evaluation of upfront docetaxel in metastatic castration-sensitive prostate cancer
    Isaksson, Jenny
    Green, Henrik
    Papantoniou, Dimitrios
    Pettersson, Linn
    Anden, Mats
    Rosell, Johan
    Avall-Lundqvist, Elisabeth
    Elander, Nils Oskar
    [J]. WORLD JOURNAL OF CLINICAL ONCOLOGY, 2021, 12 (11): : 1009 - 1022
  • [48] Patient-reported Outcomes in Metastatic Castration-sensitive Prostate Cancer in the Adjuvant Setting
    Morgans, Alicia K.
    Stockler, Martin R.
    [J]. EUROPEAN UROLOGY FOCUS, 2019, 5 (02): : 144 - 146
  • [49] The prognostic value of pain in castration-sensitive prostate cancer
    Roberto Iacovelli
    Chiara Ciccarese
    Orazio Caffo
    Ugo De Giorgi
    Marcello Tucci
    Claudia Mosillo
    Davide Bimbatti
    Francesco Pierantoni
    Francesca Maines
    Chiara Casadei
    Consuelo Buttigliero
    Michele Milella
    Giampaolo Tortora
    [J]. Prostate Cancer and Prostatic Diseases, 2020, 23 : 654 - 660
  • [50] The prognostic value of pain in castration-sensitive prostate cancer
    Iacovelli, Roberto
    Ciccarese, Chiara
    Caffo, Orazio
    De Giorgi, Ugo
    Tucci, Marcello
    Mosillo, Claudia
    Bimbatti, Davide
    Pierantoni, Francesco
    Maines, Francesca
    Casadei, Chiara
    Buttigliero, Consuelo
    Milella, Michele
    Tortora, Giampaolo
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2020, 23 (04) : 654 - 660
12345